Company: HQL
Filing Date: 2025-05-29
Form Type: NPORT-P
Source: 0001752724-25-128179
Chunk: 47

Company: abrdn Life Sciences Investors
Filing Date: 2025-05-29
Form: NPORT-P
Chunk 47
---
, option, swaption, swap (including but not limited 
 to total return swaps, credit default swaps, and interest rate      
 swaps), warrant, other).                                            | Option |

b. Counterparty.
i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

| Counterparty Record:		1       |                        |
| Name of counterparty.         | Options Clearing Corp. |
| LEI (if any) of counterparty. | 549300CII6SLYGKNHA04   |

| i. Type, selected from among the following (put, call). Respond call                                         
 for warrants.                                                                                                | Put       
 Call      |
| ii.	Payoff profile, selected from among the following (written, purchased).  Respond purchased for warrants. | Written   
 Purchased |

3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

| Name of issuer. | Regeneron Pharmaceuticals, Inc. |
| Title of issue. | Regeneron Pharmaceuticals, Inc. |

At least one of the following other identifiers:

| Identifier. | CUSIP     |
| CUSIP.      | 75886F107 |

| Identifier.                       | ISIN (if CUSIP is not available) |
| ISIN (if CUSIP is not available). | US75886F1075                     |

iv. Number of shares or principal amount of underlying reference instrument per contract.

| Number of shares.                                                                                 |         100.00000000 |
| v.	Exercise price or rate.                                                                        |         680.00000000 |
| vi.	Exercise Price Currency Code                                                                  | United States Dollar |
| vii.	Expiration date.                                                                             |           2025-04-04 |
| viii.	Delta.                                                                                      |                 XXXX |
| ix.	Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number. |        5002.38000000 |

| For each investment held by the Fund and its consolidated subsidiaries, 
 disclose the information requested in Part C. A Fund may report         
 information for securities in